FDA to examine potential heart risks of ADHD drugs
The FDA has asked its Drug Safety and Risk Management advisory committee to examine the potential cardiovascular risks of attention ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.